Compare Global E Online Ltd (GLBE) vs Incyte Corporation (INCY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Global E Online Ltd vs Incyte Corporation — how do they compare? Global E Online Ltd trades at $41.4 (market cap $6.87B), while Incyte Corporation trades at $120.45 (market cap $24.54B). The key difference: Incyte Corporation is far larger — about 3.6× Global E Online Ltd's market cap, and Global E Online Ltd is trading nearer its 52-week high, Incyte Corporation nearer its low. Which is the better fit depends on your goals.
| GLBE | INCY | |
|---|---|---|
Market Cap | $6.87B | $24.54B |
Sector | Technology | Health |
52-Week High | $42.32 | $129.93 |
52-Week Low | $27.54 | $81.61 |
Enterprise Value | $6.34B | $20.04B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Global E Online Ltd
Global-e provides a platform for cross-border e-commerce, helping retailers increase international sales by localizing the shopping experience for consumers in over 200 destinations worldwide.
Read more on GLBE →About Incyte Corporation
Incyte focuses on the discovery and development of small-molecule drugs. The firm's lead drug, Jakafi, treats two types of rare blood cancer and graft versus host disease and is partnered with Novartis. Incyte's other marketed drugs include rheumatoid arthritis treatment Olumiant (licensed to Lilly), and oncology drugs Iclusig (chronic myeloid leukemia), Pemazyre (cholangiocarcinoma), Tabrecta (lung cancer), and Monjuvi (diffuse large B-cell lymphoma). The firm's first dermatology product, Opzelura, was approved in 2021 for atopic dermatitis. Incyte's pipeline includes a broad array of oncology and dermatology programs.
Read more on INCY →
